Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Legal & Regulatory

Supriya Lifescience Legal & Regulatory

Supriya Lifescience disclosed a pending case was admitted by the Supreme Court. An interim order precludes coercive action against directors while the matter is sub judice.

Source

NSE filing, NSE: SUPRIYA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Supriya Lifescience Ltd: key numbers

Share price
₹865.00
Market cap
₹6,962 Cr
Revenue (annual)
₹827.9 Cr
Net profit (annual)
₹209.1 Cr
P/E (TTM)
35.1×Sector 46.5×
Promoter holding
68.30%+0.00% QoQ
FII holding
6.45%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Supriya Lifescience Ltd

All →

Other legal & regulatory announcements

All →